Every clinic app, patient portal, and pharma tool needs the same skeleton — secure backend, AI layer, web, mobile, payments — rebuilt each time under the hardest constraints in software: privacy, ...
For a rare genetic condition, the registry is upstream of hope: no registry, no data; no data, no trial; no trial, no therapy. But families burned by institutions won’t hand their genetic data t...
Selling regulated dermatology treatments isn’t e-commerce with extra steps — it’s prescription verification, pharmacist oversight, and rules that differ by jurisdiction, usually stitched...
Confidentiality is a precondition for therapy working — patients don’t disclose what they fear will leak. Yet between-session messaging usually runs on consumer apps that undermine it. End-to-...
Oncology patient support programs are usually outsourced across three vendors, scattering cancer patients’ data and leaving the sponsor accountable for a breach it can’t see coming. A diff...
Adherence quietly decides type 2 diabetes outcomes, and it happens where most healthcare software isn’t — the between-visit gap. A structured self-management program on infrastructure the clin...
A cross-sectional study measured AI-generated type 2 diabetes information on quality, readability, and transparency — and found variance patients can’t detect. ‘The AI told me’ can...
A Nature Health study of 617,827 Copilot conversations found 40.8% seeking health education, 14.5% asking on behalf of a child or elderly parent — and that chatbots ‘can fail in triage.’...
Clinical communication quietly migrated onto consumer messengers. A self-hosted, end-to-end encrypted messaging framework offers a third option between a six-figure enterprise contract and nothing —...
Anthropic launched Claude Science — an AI workbench for researchers — and announced it will run its own drug-discovery programs for neglected diseases, aiming to compress R&D tenfold. What it...